Dergi makalesi Açık Erişim

Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction

   Taskin, Eylem; Guven, Celal; Kaya, Salih Tunc; Sariman, Melda; Emrence, Zeliha; Ekmekci, Sema Sirma; Abaci, Neslihan; Sevgiler, Yusuf; Akcakaya, Handan

Purpose: Adriamycin (APR) is a commonly used anti-cancer drug. ADR has toxic effects on cardiomyocytes and leads to heart failure. However, the underlying mechanism(s) by which ADR causes heart failure is still not clarified exactly. The aim of present study is to investigate whether ADR-induced heart failure is mediated via HMGB1/TLR4 to initiate the apoptosis through MAPK/AMPK pathways.

Dosyalar (275 Bytes)
Dosya adı Boyutu
bib-fafa85e0-f97f-4532-83ba-0be3294d700b.txt
md5:93959a568f6be3067c9a3cad8e896d64
275 Bytes İndir
25
5
görüntülenme
indirilme
Görüntülenme 25
İndirme 5
Veri hacmi 1.4 kB
Tekil görüntülenme 21
Tekil indirme 5

Alıntı yap